Nationwide Fund Advisors Amgen Inc Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $76.4 Million - $85.4 Million	-452,798 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$167.29 - $191.0 $6.01 Million - $6.86 Million	-35,927 Reduced 7.35%	452,798 $84.4 Million
Q2 2017 Aug 10, 2017	BUY	N/A	488,725	488,725 $84.2 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.